Kymera Therapeutics (KYMR) Property, Plant & Equipment (Net) (2019 - 2026)

Kymera Therapeutics (KYMR) Property, Plant & Equipment (Net) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 642,333.36
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 31.48 Mn
10 Kymera Therapeutics 10.84 Bn 10.19 Bn - 41.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 41.62 Mn
Mar 31, 2026 41.62 Mn
Dec 31, 2025 43.18 Mn
Dec 31, 2025 43.18 Mn
Sep 30, 2025 45.13 Mn
Sep 30, 2025 45.13 Mn
Jun 30, 2025 48.57 Mn
Jun 30, 2025 48.57 Mn
Mar 31, 2025 49.17 Mn
Mar 31, 2025 49.17 Mn
Dec 31, 2024 50.46 Mn
Dec 31, 2024 50.46 Mn
Sep 30, 2024 51.24 Mn
Sep 30, 2024 51.24 Mn
Jun 30, 2024 51.74 Mn
Jun 30, 2024 51.74 Mn
Mar 31, 2024 49.34 Mn
Mar 31, 2024 49.34 Mn
Dec 31, 2023 48.13 Mn
Dec 31, 2023 48.13 Mn